Aarti Pharmalabs Limited (IN:AARTIPHARM)
:AARTIPHARM
Want to see IN:AARTIPHARM full AI Analyst Report?
Total Valuation
Aarti Pharmalabs Limited has a market cap or net worth of ₹63.78B. The enterprise value is ₹70.68B.
Market Cap₹63.78B
Enterprise Value₹70.68B
Share Statistics
Aarti Pharmalabs Limited has 90,657,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding90,657,750
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aarti Pharmalabs Limited’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.19%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)11.19%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee10.10M
Profits Per Employee1.30M
Employee Count2,095
Asset Turnover0.73
Inventory Turnover1.92
Valuation Ratios
The current PE Ratio of Aarti Pharmalabs Limited is 35.6. Aarti Pharmalabs Limited’s PEG ratio is 0.98.
PE Ratio35.6
PS Ratio3.23
PB Ratio3.43
Price to Fair Value3.43
Price to FCF-96.96
Price to Operating Cash Flow64.90
PEG Ratio0.98
Income Statement
In the last 12 months, Aarti Pharmalabs Limited had revenue of 21.15B and earned 2.72B in profits. Earnings per share was 30.06.
Revenue21.15B
Gross Profit9.87B
Operating Income3.77B
Pretax Income3.61B
Net Income2.72B
EBITDA4.74B
Earnings Per Share (EPS)30.06
Cash Flow
In the last 12 months, operating cash flow was 996.13M and capital expenditures -2.16B, giving a free cash flow of -1.17B billion.
Operating Cash Flow996.13M
Free Cash Flow-1.17B
Free Cash Flow per Share-12.89
Dividends & Yields
Aarti Pharmalabs Limited pays an annual dividend of ₹2.5, resulting in a dividend yield of 0.67%
Dividend Per Share₹2.5
Dividend Yield0.67%
Payout Ratio18.90%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.83
52-Week Price Change-18.41%
50-Day Moving Average689.59
200-Day Moving Average764.82
Relative Strength Index (RSI)50.07
Average Volume (3m)18.67K
Important Dates
Aarti Pharmalabs Limited upcoming earnings date is May 25, 2026, TBA (Not Confirmed).
Last Earnings DateFeb 9, 2026
Next Earnings DateMay 25, 2026
Ex-Dividend Date―
Financial Position
Aarti Pharmalabs Limited as a current ratio of 2.01, with Debt / Equity ratio of 32.20%
Current Ratio2.01
Quick Ratio1.12
Debt to Market Cap0.06
Net Debt to EBITDA0.85
Interest Coverage Ratio14.03
Taxes
In the past 12 months, Aarti Pharmalabs Limited has paid 882.85M in taxes.
Income Tax882.85M
Effective Tax Rate0.24
Enterprise Valuation
Aarti Pharmalabs Limited EV to EBITDA ratio is 15.25, with an EV/FCF ratio of -102.70.
EV to Sales3.42
EV to EBITDA15.25
EV to Free Cash Flow-102.70
EV to Operating Cash Flow21.83
Balance Sheet
Aarti Pharmalabs Limited has ₹555.56M in cash and marketable securities with ₹6.59B in debt, giving a net cash position of -₹6.03B billion.
Cash & Marketable Securities₹555.56M
Total Debt₹6.59B
Net Cash-₹6.03B
Net Cash Per Share-₹66.54
Tangible Book Value Per Share₹208.39
Margins
Gross margin is 50.08%, with operating margin of 17.85%, and net profit margin of 12.88%.
Gross Margin50.08%
Operating Margin17.85%
Pretax Margin17.05%
Net Profit Margin12.88%
EBITDA Margin22.43%
EBIT Margin18.32%
Analyst Forecast
The average price target for Aarti Pharmalabs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-12.47%
EPS Growth Forecast-14.29%